3Chrysostomon C, Schmitt CG. Dexmedetomidine: sedation, analgesia and beyond. Expert Opin Drug Metab Toxicol. 2008,4(5):619-627.
4Gerlaeh AT, Dasta JF. Dexmedetomidine: an updated review.15.Ann Pharmaeother. 2007,41(2):245-252.
5Lam SW, Alexander E. Dexmedetomidine Use in Critical Care. AACN Adv Grit Care. 2008,19(2):113-120.
6Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus inrats. Anesthesiology. 1992,76(6)948-952.
7Hayashi, Y, Babin BC, Guo T-Z, etaL The role of pertussis toxin-sensitive g proteins in the analgesic and anesthetic actions of alpha-2 adrenergic agonists in the rat. Anesthesiology.1995,83(4):St6 - 822.
8Klamt JG, de Andrade Vicente WV, Garcia LV,et al. Effects of Dexmedetomidine-Fentanyl Infusion on Blood Pressure and Heart Rate during Cardiac Surgery in Children. Anesthesio Res Pract. 2010, 19(8): 311-316.
9Sacchetti A, Stander E, Ferguson N, et al. A randomized, controlled, double-blind trial of patlent-control]ed sedation with propofo]/remifentanil ver-sus midazo]am/fentanyl for colonoscopy. Anesth Anal. 2008, 106(2): 434-439.
10Ogawa S, Seino H, Ito H, et al. Intravenous Sedation with. Low-Dose Dexmedetomidine: Its Potential for Use in Dentistry. Anes Prog. 2008, 55 (3), 82-88.
